Ado-trastuzumab emtansine and EndaCof-C

• Generic Name: ado-trastuzumab emtansine
• Dosage Forms: n.a.
• Other Brand Names: Kadcyla

Ado-trastuzumab emtansine is used to treat a HER2-positive breast cancer. ado-trastuzumab emtansine is used both for early breast cancer and for breast cancer that has spread to other parts of the body (metastatic).

Ado-trastuzumab emtansine is usually given after other treatments have failed.

Kadcyla (ado-trastuzumab) should not be used in place of Herceptin (trastuzumab).

Ado-trastuzumab emtansine may also be used for purposes not listed in this medication guide.

• Generic Name: chlorpheniramine / codeine
• Dosage Forms: oral liquid
• Other Brand Names: Codar AR, EndaCof-C, Lexuss 210, Z-Tuss AC, Tuzistra XR, Codeprex, Cotab A, Cotab AX, Notuss-AC, Zodryl AC 25, Zodryl AC 30, Zodryl AC 35, Zodryl AC 50, Zodryl AC 40, Zodryl AC 60, Zodryl AC 80, EndaCof-C, TL-Hist CM, Zodryl AC Adult, Tuxarin ER

• This medicine is not for use in children younger than 18 years of age. The benefits of taking EndaCof-C (codeine and chlorpheniramine liquid) for a cough due to allergies, a cold, or other infection do not outweigh the risks in children. If your child has been given EndaCof-C (codeine and chlorpheniramine liquid) or if you have any questions, talk with your child's doctor.